Status:
COMPLETED
Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty.
Lead Sponsor:
McMaster University
Conditions:
Breast Reduction
Reduction Mammoplasty
Eligibility:
FEMALE
18-85 years
Brief Summary
The investigators hope to answer the question, "does ketorolac increase the risk of hematoma after reduction mammoplasty?" using a case-control study. All patients who developed a hematoma post reduct...
Detailed Description
The electronic health record databases of St. Joseph's Healthcare Hamilton and Hamilton Health Sciences will be searched, using the coding system, for all cases of reduction mammoplasty with post--ope...
Eligibility Criteria
Inclusion
- Cases:
- \- Patients who developed hematoma post-reduction mammoplasty requiring repeat surgery
- Controls:
- \- Uncomplicated bilateral reduction mammoplasty
Exclusion
- Hematoma patients treated with observation or needle aspiration
- Concomitant surgeries in addition to the reduction mammoplasty
- Allergy/sensitivity to non-steroidal anti-inflammatory drugs
- Unilateral reduction mammoplasty
- Male reduction mammoplasty
- Documented bleeding disorders
Key Trial Info
Start Date :
September 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03280043
Start Date
September 1 2015
End Date
August 20 2017
Last Update
September 12 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 3Z5
2
Hamilton Health Sciences
Hamilton, Ontario, Canada, L8N3Z5